Tempest Therapeutics
TPST
TPST
47 hedge funds and large institutions have $27.9M invested in Tempest Therapeutics in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Holders
47
Holding in Top 10
–
Calls
$4K
Puts
$5K
Top Buyers
| 1 | +$1.15M | |
| 2 | +$1.14M | |
| 3 | +$391K | |
| 4 |
DMK
David M. Knott
|
+$175K |
| 5 |
D.E. Shaw & Co
New York
|
+$116K |
Top Sellers
| 1 | -$1.91M | |
| 2 | -$713K | |
| 3 | -$185K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$180K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$176K |